APTO stock news

SAN DIEGO and TORONTO, Oct. 10, 2019 -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated. Read more
If you want to know who really controls Aptose Biosciences Inc. (TSE:APS), then you'll have to look at the makeup of… Read more

Aptose Biosciences beats by $0.03

08:03pm, Tuesday, 07'th May 2019
Aptose Biosciences (APTO): Q1 GAAP EPS of -$0.14 beats by $0.03. Press Release Read more
Checking in on shares of Aptose Bioscns (APTO), we can see that the current opinion signal on the stock for today’s session is 16% Sell. Looking back at the last month, the opinion signal reads 96% Read more
Both Harpoon Therapeutics Inc. (NASDAQ:HARP) and Aptose Biosciences Inc. (NASDAQ:APTO) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards t Read more
Aptose Biosciences Inc. (NASDAQ:APTO) (TSE:APS) – Research analysts at Oppenheimer lowered their FY2021 earnings per share estimates for shares of Aptose Biosciences in a research note issued to inv Read more
Tracking recent technical action on shares of Aptose Bioscns (APTO), we have identified that Span A is now above Span B. Following these signals, traders may be watching to see if the stock is poised Read more

Proudly made at